{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:13:01Z","timestamp":1791969181743,"version":"4.3.4"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T00:00:00Z","timestamp":1437436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0133672","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T18:12:47Z","timestamp":1437502367000},"page":"e0133672","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes"],"prefix":"10.1371","volume":"10","author":[{"given":"Stine B.","family":"Thomsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette P.","family":"Gjesing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla N.","family":"Rathcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus T.","family":"Ekstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Eiberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluf","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2009.07.031","article-title":"Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome","volume":"314","author":"E Maury","year":"2010","journal-title":"Mol.Cell Endocrinol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MED.0b013e3283444b09","article-title":"Obesity, insulin resistance and free fatty acids","volume":"18","author":"G Boden","year":"2011","journal-title":"Curr.Opin.Endocrinol.Diabetes Obes"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diacare.27.3.813","article-title":"Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes","volume":"27","author":"JC Pickup","year":"2004","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/geno.1997.4778","article-title":"Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation","volume":"43","author":"M Rehli","year":"1997","journal-title":"Genomics"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1475-2840-8-61","article-title":"YKL-40-an emerging biomarker in cardiovascular disease and diabetes","volume":"8","author":"CN Rathcke","year":"2009","journal-title":"Cardiovasc.Diabetol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00011-006-0076-y","article-title":"YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis","volume":"55","author":"CN Rathcke","year":"2006","journal-title":"Inflamm.Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fphys.2013.00122","article-title":"YKL-40 acts as an angiogenic factor to promote tumor angiogenesis","volume":"4","author":"R Shao","year":"2013","journal-title":"Front Physiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.atherosclerosis.2010.02.035","article-title":"Increased YKL-40 expression in patients with carotid atherosclerosis","volume":"211","author":"AE Michelsen","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14017430802220567","article-title":"YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease","volume":"42","author":"Y Wang","year":"2008","journal-title":"Scand.Cardiovasc.J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/MCA.0b013e328241d991","article-title":"Serum YKL-40 levels in patients with coronary artery disease","volume":"18","author":"M Kucur","year":"2007","journal-title":"Coron.Artery Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00011-005-0010-8","article-title":"YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance","volume":"55","author":"CN Rathcke","year":"2006","journal-title":"Inflamm.Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2337\/dc08-1144","article-title":"YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria","volume":"32","author":"CN Rathcke","year":"2009","journal-title":"Diabetes Care"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1158\/1055-9965.EPI-05-0011","article-title":"Serum YKL-40, a new prognostic biomarker in cancer patients?","volume":"15","author":"JS Johansen","year":"2006","journal-title":"Cancer Epidemiol.Biomarkers Prev"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00011-010-0266-5","article-title":"The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease","volume":"60","author":"ND Mygind","year":"2011","journal-title":"Inflamm.Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e47094","DOI":"10.1371\/journal.pone.0047094","article-title":"The Association between genetic variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and the lipid profile in a Danish population","volume":"7","author":"SB Thomsen","year":"2012","journal-title":"PLoS.One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(13)62219-9","article-title":"The many faces of diabetes: a disease with increasing heterogeneity","volume":"383","author":"T Tuomi","year":"2014","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.smim.2012.12.001","article-title":"The immune system&apos;s involvement in obesity-driven type 2 diabetes","volume":"24","author":"CJ Shu","year":"2012","journal-title":"Semin.Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s00125-005-1764-9","article-title":"An immune origin of type 2 diabetes?","volume":"48","author":"H Kolb","year":"2005","journal-title":"Diabetologia"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00125-012-2484-6","article-title":"Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traits","volume":"55","author":"AP Gjesing","year":"2012","journal-title":"Diabetologia"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"KG Alberti","year":"1998","journal-title":"Diabet.Med"},{"key":"ref21","article-title":"World Health Organization Diagnosis and Classification of Diabetes Mellitus: Report of a WHO Consultation. Part 1","year":"1999"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00125-014-3207-y","article-title":"High heritability and genetic correlation of intravenous glucose- and tolbutamide-induced insulin secretion among non-diabetic family members of type 2 diabetic patients","volume":"57","author":"AP Gjesing","year":"2014","journal-title":"Diabetologia"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/clinchem\/39.4.578","article-title":"Enzyme immunoassay for intact human insulin in serum or plasma","volume":"39","author":"L Andersen","year":"1993","journal-title":"Clin.Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1007\/s001250100651","article-title":"Genetic variability of the SUR1 promoter in relation to beta-cell function and Type II diabetes mellitus","volume":"44","author":"T Hansen","year":"2001","journal-title":"Diabetologia"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"E401","DOI":"10.1152\/ajpendo.00674.2007","article-title":"The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance","volume":"295","author":"MA Abdul-Ghani","year":"2008","journal-title":"Am.J.Physiol Endocrinol.Metab"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2337\/dc06-1240","article-title":"The BIGTT test: a novel test for simultaneous measurement of pancreatic beta-cell function, insulin sensitivity, and glucose tolerance","volume":"30","author":"T Hansen","year":"2007","journal-title":"Diabetes Care"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0169-2607(86)90106-9","article-title":"MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test","volume":"23","author":"G Pacini","year":"1986","journal-title":"Comput.Methods Programs Biomed"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1086\/301844","article-title":"Multipoint quantitative-trait linkage analysis in general pedigrees","volume":"62","author":"L Almasy","year":"1998","journal-title":"Am.J.Hum.Genet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s11695-009-9917-4","article-title":"YKL-40 is elevated in morbidly obese patients and declines after weight loss","volume":"19","author":"M Hempen","year":"2009","journal-title":"Obes.Surg"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.2337\/db08-0182","article-title":"Plasma YKL-40: a BMI-independent marker of type 2 diabetes","volume":"57","author":"AR Nielsen","year":"2008","journal-title":"Diabetes"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1210\/jc.2010-0994","article-title":"Increased circulating and visceral adipose tissue expression levels of YKL-40 in obesity-associated type 2 diabetes are related to inflammation: impact of conventional weight loss and gastric bypass","volume":"96","author":"V Catalan","year":"2011","journal-title":"J.Clin.Endocrinol.Metab"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.4049\/jimmunol.181.7.5167","article-title":"YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages","volume":"181","author":"S Letuve","year":"2008","journal-title":"J.Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ana.22220","article-title":"Elevated plasma YKL-40 levels and ischemic stroke in the general population","volume":"68","author":"AD Kjaergaard","year":"2010","journal-title":"Ann.Neurol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.biocel.2005.11.008","article-title":"Contribution of adipocyte-derived factors to beta-cell dysfunction in diabetes","volume":"38","author":"YF Zhao","year":"2006","journal-title":"Int.J.Biochem.Cell Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/eurheartj\/ehn387","article-title":"Adipose tissue dysfunction in obesity, diabetes, and vascular diseases","volume":"29","author":"GR Hajer","year":"2008","journal-title":"Eur.Heart J"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2362.2010.02446.x","article-title":"YKL-40 in type 2 diabetic patients with different levels of albuminuria","volume":"41","author":"JM Brix","year":"2011","journal-title":"Eur.J.Clin.Invest"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1475-2840-10-54","article-title":"YKL-40 levels are independently associated with albuminuria in type 2 diabetes","volume":"10","author":"AK Rondbjerg","year":"2011","journal-title":"Cardiovasc.Diabetol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJMoa0708801","article-title":"Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function","volume":"358","author":"C Ober","year":"2008","journal-title":"N.Engl.J.Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1186\/ar3391","article-title":"Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjects","volume":"13","author":"KR Nielsen","year":"2011","journal-title":"Arthritis Res.Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.rmed.2006.12.006","article-title":"A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker","volume":"101","author":"A Kruit","year":"2007","journal-title":"Respir.Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/jmedgenet-2013-101908","article-title":"Genetic variants in CHI3L1 influencing YKL-40 levels: resequencing 900 individuals and genotyping 9000 individuals from the general population","volume":"50","author":"AD Kjaergaard","year":"2013","journal-title":"J.Med.Genet"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cyto.2010.12.018","article-title":"Genetic polymorphisms in chitinase 3-like 1 (CHI3L1) are associated with circulating YKL-40 levels, but not with angiographic coronary artery disease in a Chinese population","volume":"54","author":"JL Zheng","year":"2011","journal-title":"Cytokine"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1164\/rccm.200809-1422OC","article-title":"Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy","volume":"179","author":"MH Sohn","year":"2009","journal-title":"Am.J.Respir.Crit Care Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1086\/510438","article-title":"Functional variants in the promoter region of Chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia","volume":"80","author":"X Zhao","year":"2007","journal-title":"Am.J.Hum.Genet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0133672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T09:55:13Z","timestamp":1599299713000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0133672"}},"subtitle":[],"editor":[{"given":"Marco Giorgio","family":"Baroni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,21]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0133672","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,21]]}}}